WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004093850) TABLET WITH COLOURED CORE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/093850    International Application No.:    PCT/IB2004/001702
Publication Date: 04.11.2004 International Filing Date: 23.04.2004
Chapter 2 Demand Filed:    22.11.2004    
IPC:
A61K 9/20 (2006.01), A61K 9/28 (2006.01)
Applicants: JAGOTEC AG [CH/CH]; Eptingerstrasse 51, CH-4132 Muttenz (CH) (For All Designated States Except US).
VERGNAULT, Guy [FR/FR]; (FR) (For US Only).
GRENIER, Pascal [FR/FR]; (FR) (For US Only).
DRAGAN, Christophe [FR/FR]; (FR) (For US Only)
Inventors: VERGNAULT, Guy; (FR).
GRENIER, Pascal; (FR).
DRAGAN, Christophe; (FR)
Agent: BASSIL, Nicholas, Charles; Kilburn & Strode, 20 Red Lion Street, London WC1R 4PJ (GB)
Priority Data:
0309343.2 24.04.2003 GB
Title (EN) TABLET WITH COLOURED CORE
(FR) COMPRIME A NOYAU COLORE
Abstract: front page image
(EN)Press-coated tablets comprising a core and a coating. The core contains an active substance and a colouring agent such that when the tablet is exposed to penetrating radiation the core is contrasted with the coating and is visible through the coating. The invention also relates to the use' of a colouring agent or excipient in such tablets to determine whether the core is centrally located within the core, to check the integrity of the core, and to ensure that there is no contaminating core material on or near the surface of the coating.
(FR)Doubles comprimés comprenant un noyau et un enrobage. Le noyau contient une substance active et un colorant, de telle sorte que, lorsque le comprimé est exposé à un rayonnement pénétrant, le noyau contraste avec l'enrobage et est visible à travers ce dernier. L'invention se rapporte également à l'utilisation d'un excipient ou d'un colorant dans de tels comprimés pour déterminer si le noyau est centré à l'intérieur de l'enrobage, contrôler l'intégrité du noyau et vérifier si de la matière contaminante issue du noyau ne se trouve pas sur ou à proximité de la surface de l'enrobage.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)